JOSOLYNE_MEDICAL_SERVICES - Accounts


Company Registration No. 7266200 (England and Wales)
JOSOLYNE MEDICAL SERVICES LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2019
PAGES FOR FILING WITH REGISTRAR
JOSOLYNE MEDICAL SERVICES LIMITED
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 4
JOSOLYNE MEDICAL SERVICES LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT 30 APRIL 2019
30 April 2019
- 1 -
2019
2018
Notes
£
£
£
£
Non-current assets
Intangible assets
2
212,576
239,156
Current assets
Trade and other receivables
3
13,384
19,443
Cash and cash equivalents
239,075
219,383
252,459
238,826
Current liabilities
4
(100,722)
(113,874)
Net current assets
151,737
124,952
Total assets less current liabilities
364,313
364,108
Equity
Called up share capital
5
100
100
Capital redemption reserve
50
50
Retained earnings
364,163
363,958
Total equity
364,313
364,108

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

For the financial year ended 30 April 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 4 September 2019 and are signed on its behalf by:
N M Pace
A Earnshaw
Director
Director
Company Registration No. 7266200
JOSOLYNE MEDICAL SERVICES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2019
- 2 -
1
Accounting policies
Company information

Josolyne Medical Services Limited is a private company limited by shares incorporated in England and Wales. The registered office is Silk House, Park Green, Macclesfield, Cheshire, SK11 7QW.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Revenue

Revenue is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

JOSOLYNE MEDICAL SERVICES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2019
1
Accounting policies
(Continued)
- 3 -
Basic financial assets

Trade receivables, loans and other receivables that have fixed or determinable payments that are not quoted in an active market are classified as 'loans and receivables'. Loans and receivables are measured at amortised cost using the effective interest method, less any impairment.

Basic financial liabilities

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

2
Intangible fixed assets
Goodwill
£
Cost
At 1 May 2018 and 30 April 2019
406,250
Amortisation and impairment
At 1 May 2018
167,094
Amortisation charged for the year
26,580
At 30 April 2019
193,674
Carrying amount
At 30 April 2019
212,576
At 30 April 2018
239,156
JOSOLYNE MEDICAL SERVICES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2019
- 4 -
3
Trade and other receivables
2019
2018
Amounts falling due within one year:
£
£
Trade receivables
13,384
19,443
4
Current liabilities
2019
2018
£
£
Taxation and social security
31,899
35,974
Other payables
68,823
77,900
100,722
113,874
5
Called up share capital
2019
2018
£
£
Ordinary share capital
Issued and fully paid
100 Ordinary of £1 each
100
100

 

2019-04-302018-05-01falseCCH SoftwareCCH Accounts Production 2019.200No description of principal activity04 September 2019Mrs N  PaceA  Earnshaw72662002018-05-012019-04-3072662002019-04-3072662002018-04-307266200core:NetGoodwill2019-04-307266200core:NetGoodwill2018-04-307266200core:CurrentFinancialInstruments2019-04-307266200core:CurrentFinancialInstruments2018-04-307266200core:ShareCapital2019-04-307266200core:ShareCapital2018-04-307266200core:CapitalRedemptionReserve2019-04-307266200core:CapitalRedemptionReserve2018-04-307266200core:RetainedEarningsAccumulatedLosses2019-04-307266200core:RetainedEarningsAccumulatedLosses2018-04-307266200bus:Director12018-05-012019-04-307266200bus:Director32018-05-012019-04-307266200core:Goodwill2018-05-012019-04-307266200core:NetGoodwill2018-04-307266200core:NetGoodwill2018-05-012019-04-307266200bus:PrivateLimitedCompanyLtd2018-05-012019-04-307266200bus:FRS1022018-05-012019-04-307266200bus:AuditExemptWithAccountantsReport2018-05-012019-04-307266200bus:SmallCompaniesRegimeForAccounts2018-05-012019-04-307266200bus:Director22018-05-012019-04-307266200bus:FullAccounts2018-05-012019-04-30xbrli:purexbrli:sharesiso4217:GBP